Leukemia & lymphoma/Leukemia and lymphoma

译名:白血病与淋巴瘤

LEUKEMIA & LYMPHOMA

SCIEJCR Q3

1-3

2026

影响因子区间

平台估算

投稿周期

12%

2025

中国作者发文占比

£3490.00 GBP / $5090.00 USD / €3990.00 EUR.

费用说明

收费

期刊简介:Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor

【译文】白血病与淋巴瘤在其第四十年继续为高质量的临床、转化和基础科学研究以及与血液恶性肿瘤所有方面的原创观察提供了一个国际论坛。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1026-8022
eISSN
1029-2403
出版频率
月刊
创刊年份
1989
投稿网址
http://mc.manuscriptcentral.com/glal
最近更新
2026-04-02 18:16:40
Leukemia & lymphoma/Leukemia and lymphoma

指标当前值近三年趋势
JCR分区Q3
暂无
影响因子区间1-3
暂无